Supplementary Data
Supplementary Figure A. Plasma levels of ALT and AST upon a single administration of Pten PS-ASOs at 100 or 400 mg/kg for 96 h. N=3 per group. 2' F modifications are highlighted in red. B. PS-ASOs were administered subcutaneously at 25, 50, or 100 mg/kg on day 1, and BALB/c mice were sacrificed on day 4 (after 96 h). N=3 per group.
Figure S2. Overview of liver transcriptome changes from mice administered with PS-ASOs modified with MOE (ION-116847), cEt (ION-582801), or F (ION-404130).
The volcano plots of sample T3 (F ION-404130) vs. S (saline) (A.), T2 (cEt ION-582801) vs. S (saline) (B.), and T1 (MOE ION-116847) vs. S (saline) (C.). The volcano plot shows the distribution of differentially expressed probes according to fold-change (x-axis) and significance (negative logarithm of the P-value on the y-axis).
Standard selection criteria to identify differentially expressed genes are established at log2(Ratio) ≧1, and P-value < 0.05 (Blue dots in figure) . The red dashed line is the P-value cut-off (0.05), and the green dotted line is the fold change cut-off (log2(Ratio) ≧ 1). Expression data are plotted for all probes excluding control and flagged probes.
D.
Principal Component Analysis (PCA) was performed to evaluate any differences among biological replicates and their treatment conditions. The variable of the first three principal components (PC1, PC2, PC3) for this study are 78.97%, 12.28% and 3.40% respectively. A subset of differentially expressed genes was selected for PCA analysis.
Figure S3. Hepatotoxicity in mice administered with 2' F PS-ASO (ION-404130) was confirmed by liver transcriptome results.
Expression comparison of a subset of transcripts whose levels are subjected to increase (A.) or decrease (B.) during hepatotoxicity suggest the occurrence of hepatotoxicity in mice administered with 2' F PS-ASO . Data was summarized from microarray results (N=3). Expression comparison of a subset of transcripts whose levels are subjected to increase (A.) or decrease (B.) during liver necrosis suggests the occurrence of necrosis in mice administered with 2' F PS-ASO (ION-404130).
Data was summarized from microarray results (N=3).

Figure S5. Toxic 2' F modified PS-ASOs reduced levels of P54nrb and PSF proteins in vivo.
Western analysis of liver proteins isolated from animals administrated with saline, 2' MOE (ION-1146604, ION-1146613, and ION-450987), or 2' F (ION-1147368, ION-1147366, and ION-1147360) PS-ASOs. ASOs were administered at 400 mg/kg and animals were sacrificed at 96 h after the administration of ASOs. Bip serves as a loading control. PARPCL-cleaved PARP. Figure S6 . PS-ASOs localize rapidly to paraspeckles after electroporation.
PS-ASOs were electroporated into HeLa cells transiently overexpressing GFP-PSF. Figure S1 Figure S10 K: # genes in gene set; k: # genes in overlap 
